These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32622368)

  • 21. EXUDATIVE RETINAL DETACHMENT CAUSED BY A CHOROIDAL NEOVASCULAR MEMBRANE IN HALLERMANN-STREIFF SYNDROME.
    AlAli A; Bourgault S; Clark I; Lam WC
    Retin Cases Brief Rep; 2018 Winter; 12(1):45-47. PubMed ID: 27648586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choroidal neovascularization following argon laser photocoagulation for central serous chorioretinopathy.
    Fekih O; Mabrouk S; Zgolli MH; Bakir K; Zghal I; Nacef L
    Tunis Med; 2019 Jan; 97(1):157-162. PubMed ID: 31535710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.
    Iannaccone A; Kerr NC; Kinnick TR; Calzada JI; Stone EM
    Arch Ophthalmol; 2011 Feb; 129(2):211-7. PubMed ID: 21320969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy].
    Prieto-Calvo E; Torrón-Fernández Blanco C; Egea-Estopiñán C; Güerri-Monclús N; Ferrer-Novella E; Ruiz-Moreno O; Pablo-Julvez LE
    Arch Soc Esp Oftalmol; 2012 May; 87(5):149-52. PubMed ID: 22554558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease].
    Velazquez-Villoria D; Macià Badia C; Rigo Quera J; Velez-Escola L; Arcos-Algaba G; Martínez-Castillo V; García-Arumí J
    Arch Soc Esp Oftalmol; 2014 Oct; 89(10):405-7. PubMed ID: 24508228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral choroidal neovascular membrane as a herald lesion for Crohn's disease.
    Thomas BJ; Emanuelli AA; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(1):62-5. PubMed ID: 24392915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report].
    Krzyzanowska-Berkowska P; Barć A; Oficjalska J
    Klin Oczna; 2011; 113(1-3):60-3. PubMed ID: 21853954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
    Lee IJ; Maccheron LJ; Kwan AS
    J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema.
    Ünlü C; Erdogan G; Gunay BO; Kardes E; Akcay BI; Ergin A
    Int Ophthalmol; 2017 Feb; 37(1):147-158. PubMed ID: 27154721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab.
    Kumar N; Tigari B; Dogra M; Singh R
    Indian J Ophthalmol; 2018 Sep; 66(9):1358-1360. PubMed ID: 30127172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy.
    Cornish KS; Williams GJ; Gavin MP; Imrie FR
    Eur J Ophthalmol; 2011; 21(4):440-5. PubMed ID: 21188681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal bevacizumab in choroidal neovascularization associated with congenital choroidal and optic nerve coloboma in children: long-term improvement in visual acuity.
    Naithani P; Vashisht N; Mandal S; Sankaran P; Garg S
    J AAPOS; 2010 Jun; 14(3):288-90. PubMed ID: 20603066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].
    Perol J; Wolff B; Sahel JA; Le Mer Y
    J Fr Ophtalmol; 2011 May; 34(5):281-6. PubMed ID: 21507509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
    Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
    Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
    Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
    Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.
    Ranjan R; Agarwal M
    Indian J Ophthalmol; 2018 Jun; 66(6):863-865. PubMed ID: 29786006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.